The frameshift variant in the CHEK2 gene, related to the TP53 pathway, has been previously described in an Italian family with hereditary breast/ovarian cancer (HBOC) and is considered to be likely pathogenetic for cancer predisposition syndromes. This evidence concerns the gene CHEK2 and cancer.